Simpson John M, Savis Alexandra, Rawlins Debbie, Qureshi Shakeel, Sinha Manish D
Department of Congenital Heart Disease, Evelina Children's Hospital, Guys and St Thomas NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK.
Eur J Echocardiogr. 2010 Apr;11(3):271-7. doi: 10.1093/ejechocard/jep211. Epub 2009 Dec 15.
Patients with chronic kidney disease are at high risk of cardiovascular morbidity and mortality. Increased left ventricular mass (LVM) has been shown to be an adverse prognostic factor. LVM may be indexed for body size by different methods related to height, weight, or body surface area (BSA). Our Null hypothesis was that different methods of indexation would not influence categorization as to whether LVM was within normal limits or increased.
Prospective study in children with renal disease. M-mode echocardiography assessed by single investigator blinded to medical therapy. Three different partition values and two different published z-scores were used: Method 1: indexation of LVM to the allometric height in metres raised to the power of 2.7 (m(2.7)), value of 38.6 g/m(2.7) denotes 95th percentile. Method 2: indexation of LVM by body weight, ratio of LVM in gm/kg of >3.0 indicating LVH. Method 3: indexation by BSA, 88.9 g/m(2) represents 95th percentile. Z-score based methods from recent studies with z-score >1.65 denoting LVH, Method 4: z-score indexed either for BSA or Method 5, z-score indexed for height(2.7). One hundred and twenty-three echocardiograms were performed in 80 patients with a mean +/- SD age of 13.1 +/- 3.1 years, height 147.2 +/- 15.3 cm, weight 46.4 +/- 15.8 kg, and body mass index 20.8 +/- 4.1 kg/m(2). Method 1, LVH was observed in 68 (55.3%) studies. Method 2, 32 (26%) studies had LVM/kg >3.0. Method 3, 51 studies (41.5%) demonstrated LVH. Method 4, 22 (17.9%) studies demonstrated LVH and Method 5, 25 studies (20%) demonstrated LVH (chi(2) test, P < 0.001).
Different methods of indexation have a profound influence on the categorization of children with respect to LVH. This will have a major impact on the number of patients who are treated as per current guidelines especially in high-risk groups.
慢性肾脏病患者心血管发病和死亡风险较高。左心室质量(LVM)增加已被证明是一个不良预后因素。LVM可通过与身高、体重或体表面积(BSA)相关的不同方法进行体型指数化。我们的零假设是,不同的指数化方法不会影响LVM是否在正常范围内或增加的分类。
对肾病患儿进行前瞻性研究。由对治疗不知情的单一研究者进行M型超声心动图评估。使用了三种不同的划分值和两种不同的已发表z评分:方法1:将LVM指数化为身高(米)的2.7次幂(m(2.7)),38.6 g/m(2.7)的值表示第95百分位数。方法2:按体重对LVM进行指数化,LVM(克/千克)比值>3.0表示左心室肥厚(LVH)。方法3:按BSA进行指数化,88.9 g/m(2)代表第95百分位数。基于近期研究的z评分方法,z评分>1.65表示LVH,方法4:按BSA进行z评分指数化,或方法5:按身高(2.7)进行z评分指数化。对80例患者进行了123次超声心动图检查,患者平均年龄±标准差为13.1±3.1岁,身高147.2±15.3 cm,体重46.4±15.8 kg,体重指数20.8±4.1 kg/m(2)。方法1中,68项(55.3%)研究观察到LVH。方法2中,32项(26%)研究的LVM/千克>3.0。方法3中,51项(41.5%)研究显示LVH。方法4中,22项(17.9%)研究显示LVH,方法5中,25项(20%)研究显示LVH(卡方检验,P<0.001)。
不同的指数化方法对儿童LVH的分类有深远影响。这将对按照当前指南治疗的患者数量产生重大影响,尤其是在高危人群中。